Association of IL28B Polymorphism with Fibrosis, Liver Inflammation, Gender Respective Natural History of Hepatitis C Virus in Egyptian Patients with Genotype 4

被引:6
|
作者
Youssef, Samar Samir [1 ]
Abbas, Eman Abd El-Razek [1 ]
Abd el Aal, Asmaa Mostafa [1 ]
el Zanaty, Taher [2 ]
Seif, Sameh Mohamed [3 ]
机构
[1] Natl Res Ctr, Microbial Biotechnol Dept, Cairo 11231, Egypt
[2] Cairo Univ, Fac Med, Dept Internal Med, Cairo, Egypt
[3] Natl Hepatol & Trop Med Res Inst, Cairo, Egypt
关键词
GENETIC-VARIATION; SPONTANEOUS CLEARANCE; PROGRESSION; INFECTION; THERAPY; SUSCEPTIBILITY;
D O I
10.1089/jir.2013.0036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The polymorphism of interleukin 28B (IL28B) rs12979860 is associated with spontaneous and treatment-induced clearance in hepatitis C virus (HCV) genotype 4 (G4). However, there is no information on its interaction with gender, moreover its association with intrahepatic inflammation in North Africans is not studied and its association with fibrosis in North Africans (especially Egyptians) is controversial. This study aims to explore the association between the minor allele of the IL28B rs12979860 polymorphism with gender, fibrosis and necroinflammation in Egyptian G4 HCV patients. IL28B rs12979860 was genotyped in 224 individuals, including 100 healthy controls and 124 consecutive patients with chronic HCV. Results showed (1) IL28B rs12979860 minor alleles associated with susceptibity to chronic HCV mainly in men not women, (2) no association between IL28B rs12979860 with fibrosis and necroinflammation activity, (3) the IL28B rs12979860 TT genotype associated with severe fibrosis in women only and with the necroinflammation activity in men using a recessive model. In conclusion, the IL28B rs12979860 polymorphism is not associated with fibrosis and liver inflammation in Egyptian HCV G4. Nonetheless, the TT genotype of IL28B rs12979860 polymorphism affects the natural history of each gender independently.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 50 条
  • [31] A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus
    Hiramine, Satoshi
    Sugiyama, Masaya
    Furusyo, Norihiro
    Uto, Hirofumi
    Ido, Akio
    Tsubouchi, Hirohito
    Watanabe, Hisayoshi
    Ueno, Yoshiyuki
    Korenaga, Masaaki
    Murata, Kazumoto
    Masaki, Naohiko
    Hayashi, Jun
    Thomas, David L.
    Mizokami, Masashi
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (10) : 1069 - 1077
  • [32] Role of IL28B Polymorphism in the Development of Hepatitis C Virus-Induced Hepatocellular Carcinoma, Graft Fibrosis, and Posttransplant Antiviral Therapy
    Eurich, Dennis
    Boas-Knoop, Sabine
    Bahra, Marcus
    Neuhaus, Ruth
    Somasundaram, Rajan
    Neuhaus, Peter
    Neumann, Ulf
    Seehofer, Daniel
    TRANSPLANTATION, 2012, 93 (06) : 644 - 649
  • [33] IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection
    Abdo, Ayman A.
    Al-Ahdal, Mohammed N.
    Khalid, Saira S.
    Helmy, Ahmed
    Sanai, Faisal M.
    Alswat, Khalid
    Al-hamoudi, Waleed
    Ali, Safiyya M.
    Al-Ashgar, Hamad I.
    Al-Mdani, Abdallah
    Albenmousa, Ali
    Al Faleh, Faleh Z.
    Al-Anazi, Mashael
    Khalaf, Nisreen
    Al-Qahtani, Ahmed
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 533 - 538
  • [34] IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus
    Guzman-Fulgencio, Maria
    Berenguer, Juan
    Garcia-Alvarez, Monica
    Fernandez-Rodriguez, Amanda
    Jimenez-Sousa, Maria A.
    Alvarez, Emilio
    Micheloud, Dariela
    Carlos Lopez, Juan
    Miralles, Pilar
    Cosin, Jaime
    Catalan, Pilar
    Resino, Salvador
    JOURNAL OF INFECTION, 2013, 66 (02) : 170 - 178
  • [35] Is there clinical utility to IL28B genotype testing in the treatment of chronic hepatitis C virus infection?
    Liapakis, AnnMarie
    Jesudian, Arun B.
    PHARMACOGENOMICS, 2012, 13 (12) : 1317 - 1319
  • [36] Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1
    Ogawa, Eiichi
    Furusyo, Norihiro
    Murata, Masayuki
    Ikezaki, Hiroaki
    Ihara, Takeshi
    Hayashi, Takeo
    Toyoda, Kazuhiro
    Taniai, Hiroaki
    Okada, Kyoko
    Kainuma, Mosaburo
    Hayashi, Jun
    JOURNAL OF HEPATOLOGY, 2012, 57 (03) : 534 - 540
  • [37] Early viral kinetics during hepatitis C virus genotype 6 treatment according to IL28B polymorphisms
    Akkarathamrongsin, Srunthron
    Payungporn, Sunchai
    Vo Duy Thong
    Poovorawan, Kittiyod
    Prapunwattana, Phisit
    Poovorawan, Yong
    Tangkijvanich, Pisit
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (30) : 10599 - 10605
  • [38] IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients
    Mostafa K El Awady
    Noha G Bader El Din
    Ashraf Tabll
    Yaser El Hosary
    Ashraf O Abdel Aziz
    Hesham El Khayat
    Mohsen Salama
    Tawfeek H Abdelhafez
    World Journal of Gastroenterology, 2013, (02) : 290 - 298
  • [39] Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism
    Ekstrom, Victoria
    Kumar, Rajneesh
    Zhao, Yi
    Yee, Mei Ling
    Sung, Cynthia
    Toh, Dorothy
    Loh, Poh Yen
    Tan, Jessica
    Teo, Eng Kiong
    Chow, Wan Cheng
    GASTROENTEROLOGY REPORT, 2017, 5 (03): : 208 - 212
  • [40] Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations
    Soh, Benjy Yi-Min
    Kumar, Rajneesh
    Ekstrom, Victoria Sze-Min
    Lin, Clement Yi-Hao
    Thangaraju, Sobhana
    Tan, Hwee Huang
    Chan, Kwai Peng
    Choong, Lina Hui Lin
    Teo, Diana
    Chow, Wan Cheng
    SINGAPORE MEDICAL JOURNAL, 2019, 60 (01) : 34 - 39